Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Thomas W, Mc Closkey"'
Autor:
Weiguo Zhong, Christina D. Swenson, Joanne Cuomo, Yeji Cho, Thomas W. Mc Closkey, Chengsen Xue
Publikováno v:
Cancer Research. 81:512-512
The success of inhibiting PD1 on T cells for cancer immunotherapy initiated strong interest in studying therapeutic antibodies to alter the adaptive immune system. As the knowledge of neoantigens, oncogenes, and autoantigens is rapidly accelerating,
Recommendations for the development and validation of flow cytometry-based receptor occupancy assays
Autor:
Barry van der Strate, John Ferbas, Virginia Litwin, Tim Wyant, Thomas W. Mc Closkey, Jennifer J. Stewart, Cherie Green, Meina Liang, Yuanxin Xu, Nicholas Jones, Carl-Magnus Högerkorp, David Lanham, Danice E. C. Wilkins, Alan Lackey, Kamila Czechowska, Maxime Moulard
Publikováno v:
Cytometry Part B: Clinical Cytometry. 90:141-149
Receptor occupancy measurements demonstrate the binding of a biotherapeutic agent to its extra-cellular target and represent an integral component of the pharmacodynamic (PD) portfolio utilized to advance the development and commercialization of a th
Autor:
Joanne Cuomo, Chengsen Xue, Chrinstina D. Swenson, Kai Chen, Thomas W. Mc Closkey, Lucie-Emily Rows
Publikováno v:
Cancer Research. 80:5593-5593
Personalized immunotherapy for cancer has become an effective treatment choice in certain oncology indications. To successfully develop such therapeutic candidates requires a deep understanding of the biology including the interaction between a varie
Autor:
Kasia E. Cortes, Hong Ji, Anne Charlotte Hegelund, Carl-Magnus Högerkorp, Karen J. Quadrini, Chengsen Xue, Thomas W. Mc Closkey, Susan M. Kennelly
Publikováno v:
Cytometry Part B: Clinical Cytometry. 90:177-190
The C5a/C5a receptor (C5aR) pathway, a key component in the proinflammatory immune response, is an attractive therapeutic target since its dysregulation is implicated in a variety of autoimmune and inflammatory disorders. The objective of the present
Publikováno v:
Cancer Research. 78:5588-5588
Circulating tumor cell (CTC) detection and characterization have recently become an integral part of precision medicine. Several large, multicenter clinical studies confirmed that the prevalence of CTC is a useful predictor of treatment efficacy in m
Publikováno v:
Cancer Research. 77:2605-2605
Flow cytometric assessment of cellular and intracellular biomarkers facilitates the development of new classes of cancer immunotherapy therapeutics. This powerful tool has multiple applications including 1) detecting PD1, PDL-1 and caspase-3 for apop
Autor:
Karen J, Quadrini, Anne Charlotte, Hegelund, Kasia E, Cortes, Chengsen, Xue, Susan M, Kennelly, Hong, Ji, Carl-Magnus, Högerkorp, Thomas W, Mc Closkey
Publikováno v:
Cytometry. Part B, Clinical cytometry. 90(2)
The C5a/C5a receptor (C5aR) pathway, a key component in the proinflammatory immune response, is an attractive therapeutic target since its dysregulation is implicated in a variety of autoimmune and inflammatory disorders. The objective of the present
Autor:
Savita Pahwa, Thomas W. Mc Closkey
Publikováno v:
Clinical Immunology Newsletter. 19:93-102
Publikováno v:
Cancer Immunology Research. 4:A026-A026
The measurement of regulatory T cells (Treg) by flow cytometry provides important information in the assessment of new anti-tumor drug candidates, particularly in regards to an immuno-oncology mechanism of action. An assay was validated using a fit-f
Publikováno v:
Hepatology. 16:191-203
Endothelial cells and macrophages are located within the hepatic sinusoids. These two cell types play an important role in the clearance of bacterially derived lipopolysaccharide from the portal circulation. Our laboratory has previously demonstrated